Australia markets closed

(SUVENPHAR.BO)

. Currency in USD
Add to watchlist
- (-)
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/03/2024
31/03/2023
31/03/2022
31/03/2021
31/03/2020
Total revenue
10,513,537
10,513,537
13,403,288
12,898,038
9,799,360
-
Cost of revenue
4,485,105
4,485,105
5,861,949
5,550,859
4,202,035
-
Gross profit
6,028,432
6,028,432
7,541,339
7,347,179
5,597,325
-
Operating expenses
Research development
-
-
85,857
103,545
110,575
141,315
Selling general and administrative
-
-
365,333
366,222
265,767
231,816
Total operating expenses
2,516,255
2,516,255
2,279,571
1,918,919
1,483,661
-
Operating income or loss
3,512,177
3,512,177
5,261,768
5,428,260
4,113,664
-
Interest expense
74,511
74,511
128,109
62,310
91,437
-
Income before tax
4,056,716
4,056,716
5,597,298
6,675,898
4,676,741
-
Income tax expense
1,053,911
1,053,911
1,484,395
2,137,850
1,053,323
-
Income from continuing operations
3,002,805
3,002,805
4,112,903
4,538,048
3,623,418
-
Net income
3,002,806
3,002,806
4,112,903
4,538,049
3,623,418
-
Net income available to common shareholders
3,002,806
3,002,806
4,112,903
4,538,049
3,623,418
-
Basic EPS
16.96
-
16.16
17.83
14.23
12.45
Diluted EPS
16.96
-
16.16
17.83
14.23
12.45
Basic average shares
254,695
-
254,511
254,565
254,565
254,565
Diluted average shares
254,695
-
254,511
254,565
254,565
254,565